Prevention and Management of Hereditary Breast Cancer-Reference-Cited by-同舟云学术

Prevention and Management of Hereditary Breast Cancer

Published:2005-03-10 Issue:8 Volume:23 Page:1656-1663
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Narod Steven A.¹,Offit Kenneth¹

Affiliation:

1. From the Centre for Research on Women's Health, University of Toronto, Toronto, Ontario, Canada; and the Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.10.035

Reference94 articles.

1. BRCA1 and BRCA2: 1994 and beyond

2. Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

3. Cancer Risks in BRCA2 Mutation Carriers

4. Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232,1991-242,

5. Whittemore AS, Gong G, Itnyre J: Prevalence and contribution of /2 mutations in breast cancer and ovarian cancer: Results from three U.S. population based case-control studies of ovarian cancer. Am J Hum Genet 60:496,1997-504, BRCA1

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SEfficacy and safety of apatinib in the treatment of patients with platinum‑resistant ovarian cancer: A systematic review and network meta‑analysis;Experimental and Therapeutic Medicine;2024-07-26

2. An overview of genetic services delivery for hereditary breast cancer;Breast Cancer Research and Treatment;2022-01-26

3. Cancer Patient Healthcare Analysis by Genomic Prediction;Intelligent Interactive Multimedia Systems for e-Healthcare Applications;2021-11-16

4. Surgical Management of Hereditary Breast Cancer;Genes;2021-08-31

5. A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer;Clinical Cancer Research;2020-12-03